Understanding why people with anxiety join trials
Part of Mental health clinical trials.
This study looks at why people with generalized anxiety disorder choose to join clinical trials. It does not test a new treatment, but helps researchers understand participation trends to improve future studies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of generalized anxiety disorder
- You are 18 years of age or older
- You are willing and able to attend scheduled visits and complete required tests and treatments
- You are not currently pregnant or breastfeeding
- You are not participating in another clinical trial at the same time
- You can provide written consent to take part
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational medication to see if it can reduce anxiety symptoms in adults with generalized anxiety disorder. Participants will receive the study drug and be monitored for safety and effectiveness.
This trial tests a new medicine called SYT-510 for adults with generalized anxiety disorder who are not currently taking medication. It aims to see if the drug reduces anxiety and is safe.
This trial compares two short-term therapies—psychoanalytic and cognitive behavioral—for people with generalized anxiety disorder (GAD). It aims to see which approach works better over 12 weekly sessions.
This study tests a new medicine (SEP-363856) for adults with generalized anxiety disorder to see if it reduces anxiety symptoms and is safe. It may help if other treatments haven't worked well.
This study is for adults who already completed an earlier phase 3 trial of this anxiety medication and are continuing it. It tests how safe and tolerable the medication is when used for a longer period for generalized anxiety disorder.
This trial tests a new medication, JNJ-99245354 (also called ITI-1284), added to your current anxiety treatment to see if it helps reduce anxiety symptoms. You may be eligible if you've already tried at least one FDA-approved treatment for generalized anxiety disorder without enough improvement.
Hear when a new Generalized Anxiety Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.